Question 1

What specific risks are associated with inhaling ultrafine particles?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study to Explore the Effects of Two Hour Inhalation of Ultrafine Carbon Black Particles on Airway Inflammation in Asthmatics clinical trial (NCT00527462). Contact the study team or your healthcare provider for specific answers.

Question 2

How will this study help improve treatments for asthma?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study to Explore the Effects of Two Hour Inhalation of Ultrafine Carbon Black Particles on Airway Inflammation in Asthmatics clinical trial (NCT00527462). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of the bronchoscopy procedure?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study to Explore the Effects of Two Hour Inhalation of Ultrafine Carbon Black Particles on Airway Inflammation in Asthmatics clinical trial (NCT00527462). Contact the study team or your healthcare provider for specific answers.

Question 4

How will my asthma be monitored during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study to Explore the Effects of Two Hour Inhalation of Ultrafine Carbon Black Particles on Airway Inflammation in Asthmatics clinical trial (NCT00527462). Contact the study team or your healthcare provider for specific answers.

Question 5

What should I do if I experience worsening symptoms during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study to Explore the Effects of Two Hour Inhalation of Ultrafine Carbon Black Particles on Airway Inflammation in Asthmatics clinical trial (NCT00527462). Contact the study team or your healthcare provider for specific answers.

What this study is about